Riskpilot← Back to searchSign inGet full accessAURICULI AS
ASActiveOrg 992003715Bjerkealleen 14E, 1363 HøvikGeneral medical practice activities · NACE 8621Est. 20072 employees
Revenue 2024
NOK 7,9M
-2% vs 2023
EBITDA margin
53.5%
+9% vs 2023
Equity ratio
92.2%
Financial strength
Net profit 2024
NOK 4,8M
+34% vs 2023
| Revenue | NOK 7,9M | -2% |
| EBITDA | NOK 4,2M | +9% |
| Net profit | NOK 4,8M | +34% |
| Total assets | NOK 15,6M | +32% |
| Equity | NOK 14,4M | +45% |
| Employees | 2 | — |
Legal name
AURICULI AS
Org number
992003715
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
13. desember 2007
Share capital
NOK 100 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Tilby lege- og medisinske tjenester, deltagelse i andre selskaper og virksomhet som herunder naturlig hører.
Address
Bjerkealleen 14E, 1363 Høvik
Phone
+4767104959
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 6 981 | 7 162 | 7 625 | 8 072 | 7 892 |
| Staff expenses | −1 022 | −1 215 | −1 117 | −1 204 | −1 148 |
| EBITDA | 3 547 | 3 182 | 4 073 | 3 867 | 4 221 |
| Depreciation & amort. | −17 | −120 | −120 | −120 | 121 |
| EBIT | 3 530 | 3 061 | 3 952 | 3 747 | 4 342 |
| Net financials | 206 | 779 | −35 | 813 | 1 465 |
| Profit before tax | 3 736 | 3 840 | 3 918 | 4 560 | 5 807 |
| Tax | 750 | 716 | 872 | 937 | 962 |
| Net profit | 2 985 | 3 124 | 3 046 | 3 623 | 4 845 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 12 035 | 11 708 | 9 061 | 11 788 | 15 607 |
| Equity | 10 960 | 3 221 | 6 267 | 9 890 | 14 385 |
| Long-term debt | 0 | 0 | 0 | 0 | 6 |
| Short-term debt | 1 075 | 8 487 | 2 794 | 1 898 | 1 216 |
| Total debt | 1 075 | 8 487 | 2 794 | 1 898 | 1 222 |
EBITDA margin
53.5%
This company
15.8%
Market median
+239% vs market
20202024
Equity ratio
92.2%
This company
38.2%
Market median
+141% vs market
20202024
Return on equity
33.7%
This company
18.4%
Market median
+83% vs market
20202024
Net profit margin
61.4%
This company
8.1%
Market median
+658% vs market
20202024
Asset turnover
0.51×
This company
1.12×
Market median
-54% vs market
20202024
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KA Deputy Member | Deputy Member | 2007 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2007 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AURICULI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kristin Andersen Bakke | Deputy Member | 0 companies |
| Harald Bakke | Chairman | 0 companies |